| Literature DB >> 33111094 |
Thomas Rauter1, Maria R Depaoli1, Helmut Bischof1, Wolfgang F Graier1,2, Roland Malli1,2.
Abstract
The metabolic activity of cells is interrelated with cell signaling, functions, and fate. Uncontrolled cancer cell proliferation requires metabolic adaptations. Research focusing on understanding the characteristics of cell metabolism is crucial for the development of novel diagnostic and therapeutic strategies. Here, we describe protocols for the ATP profiling of single cancer cells by fluorescence live-cell imaging. In response to distinct metabolic inhibitions, we record individual mitochondrial ATP dynamics using established Förster resonance energy transfer-based genetically encoded fluorescent ATP probes. For complete details on the use and execution of this protocol, please refer to Depaoli et al. (2018).Entities:
Mesh:
Substances:
Year: 2020 PMID: 33111094 PMCID: PMC7580088 DOI: 10.1016/j.xpro.2020.100048
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Step-By-Step Workflow for ATP Profiling of Live Cancer Cells Using Fluorescence Microscopy
1. Cells are seeded and grown on glass coverslips positioned in 6-well plates. 2. Cells are transfected with the plasmid encoding the mitochondria-targeted Förster Resonance Energy Transfer (FRET)-based ATP-sensor mtAT1.03. 3. The glass coverslip with adherent cells is transferred to a perfusion chamber and the perfusion system is set up and attached to the chamber allowing optimal buffer exchange during the measurements. 4. Measurement of mitochondrial ATP-dynamics of living cells via fluorescence microscopy is conducted. 5. The live-cell imaging data are analyzed, enabling a type of metabolic profiling of the tested cells by comparing mitochondrial ATP-profiles under certain conditions as a crucial metabolic parameter.
Formulation of CSB for Cell Storage before Measurement
| Component | Concentration | Amount for 1 L |
|---|---|---|
| NaCl | 138 mM | 138 mL of 1 M stock |
| KCl | 5 mM | 50 mL of 0.1 M stock |
| CaCl2 | 2 mM | 20 mL of 0.1 M stock |
| MgCl2 | 1 mM | 10 mL of 0.1 M stock |
| HEPES | 10 mM | 10 mL of 1 M stock |
| NaHCO3 | 2.6 mM | 26 mL of 0.1 M stock |
| Na2HPO4 | 0.34 mM | 3.4 mL of 0.1 M stock |
| KH2PO4 | 0.44 mM | 4.4 mL of 0.1 M stock |
| D(+)-Glucose Monohydrate | 10 mM | 1.98 g |
| Gibco MEM Vitamin solution (100x) | 1x | 10 mL |
| Gibco MEM Amino Acid solution (50x) | 1x | 20 mL |
| Penicillin-Streptomycin (10,000U/ml) | 1 % | 10 mL |
| L-Glutamine | 2.5 mM | 367 mg |
| Amphotericin B | 0.5 % | 5 mL |
| ddH2O | to 1 L | |
| NaOH | adjust pH to 7.4 |
Formulation of Isotonic EBs for Cell Super-Fusion during Live-Cell Imaging of Cellular ATP Dynamics
| Component | Concentration | Amount for 1 L |
|---|---|---|
| Basis for all EBs | ||
| NaCl | 138 mM | 138 mL of 1 M stock |
| KCl | 5 mM | 50 mL of 0.1 M stock |
| CaCl2 | 2 mM | 20 mL of 0.1 M stock |
| MgCl2 | 1 mM | 10 mL of 0.1 M stock |
| HEPES | 10 mM | 10 mL of 1 M stock |
| ddH2O | to 1 L | |
| NaOH | adjust pH to 7.4 | |
| for EB with Glucose (+ Glu) add: | ||
| D(+)-Glucose Monohydrate | 10 mM | 1.98 g |
| for EB without Glucose (– Glu) add: | ||
| D-Mannitol | 10 mM | 1.82 g |
| for EB with Oligomycin-A (+ Oligo) add: | ||
| D(+)-Glucose Monohydrate | 10 mM | 1.98 g |
| Oligomycin-A stock solution in DMSO (10 mM) | to 2 μM final conc. | 0.2 mL |
Oligomycin-A should be added freshly on the day of the measurement!
Components of the Imaging System Used in Our Laboratory
| Component | Note | Company |
|---|---|---|
| Olympus IX73 | Inverted setup is necessary due to the nature of the protocol | Olympus, Vienna, Austria |
| Omicron LEDHub | Light source equipped with 455 nm LED | Omicron, Klaus, Austria |
| Excitation filter | Semrock 427/10 Brightline HC | IDEX Health & Science, Rochester, NY, USA |
| Emission filter | Semrock | IDEX Health & Science, Rochester, NY, USA |
| Photometrics DV2 | Optical beam splitter | Photometrics, Tucson, AZ, USA |
| Retiga R1 CCD camera | Camera | TELEDYNE QIMAGING, Surrey, Canada |
| PC | For control and monitoring of measurement via imaging software | N/A |
| Visiview v4.2.0.1 | Imaging software |
Figure 2The Perfusion Chamber Applied in the Experimental Setup
The perfusion chamber (PC30, NGFI) used in the experiment is shown in the closed (A) and opened configuration (B).
(A) The positions of inlet (left, white) and outlet for the buffer (right) allow laminar flow over the imaged cells.
(B) In addition to the bottom (left) and top part of the chamber (right), the sealing ring (top) and a 30 mm glass slide (bottom) is shown. For the experiment the glass slide carrying the cells is placed in the slot of the lower chamber-part, the sealing ring is placed in the slot of the upper chamber-part and the chamber is closed via a quick-release fastener.
Recommended Confluencies at the Day of Transfection
| HeLa | HEK293a | INS-1 | |
|---|---|---|---|
| TransFast (2d) | 40% | 40%–50% | 40%–50% |
| TransFast (1d) | 40%–50% | 40%–50% | 40%–50% |
| PolyJet™ (2d) | 25%–30% | 25%–30% | 25%–30% |
| PolyJet™ (1d) | 40% | 40% | 40% |
Values are given for the cell lines HeLa, HEK293a and INS-1 for either of the two mentioned lipid-based transfection reagents (TransFast, PolyJet). “2d”: transfection performed two days before measurement; “1d”: transfection performed on the day before the measurement day.
Figure 3Exemplary Data of the ATP Profiling Protocol
(A–C) Show a single-cell response to glucose-removal measured with mtAT1.03. (A) Fluorescence intensity curves of CFP (480 nm, cyan) and FRET (535 nm, yellow) showing a mirror-inverted reaction upon glucose-removal underlining the ratiometric nature of the sensor. Values are given in arbitrary units (a.u.). (B) The single curves from A are used to calculate a ratio-value over time (grey) representing mitochondrial ATP-content. The function R0 is calculated using GraphPad Prism (dotted curve, see Data Analysis). (C) A normalized and bleaching-corrected Ratio-curve enabling a readout of the maximum delta upon glucose-removal.
(D) Fluorescence microscope images of mitochondria-targeted ATP-sensor mtAT1.03 showing the CFP- (left) and FRET-channel (right), respectively, in HeLa cells using a 40x objective and binning 4. Scale bar, 20 μm.
(E) Comparison of normalized ratios when measuring with mtAT1.03 over the course of the protocol between two example cell lines (“typeA“: red, “typeB“: blue). The example nicely illustrates the power of the single-cell imaging protocol: resolving differences in general metabolic profiles between cell lines based on their mitochondrial ATP dynamics but also minor differences between single cells of the same cell line! For data used in this figure see Depaoli et al., 2018.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| NaCl | Carl Roth, Graz, Austria | Cat#3957 |
| KCl | Carl Roth, Graz, Austria | Cat#6781 |
| MgCl2 x 6H2O | Carl Roth, Graz, Austria | Cat#2189 |
| CaCl2 x 2H2O | Carl Roth, Graz, Austria | Cat#T885 |
| NaHCO3 | Carl Roth, Graz, Austria | Cat#8551 |
| Na2HPO4 x 2H2O | Carl Roth, Graz, Austria | Cat#4984 |
| KH2PO4 | Merck, Darmstadt, Germany | Cat#A681173 |
| NaOH | Carl Roth, Graz, Austria | Cat#6771 |
| Dimethyl sulfoxide (DMSO) | Carl Roth, Graz, Austria | Cat#A994 |
| L-Glutamine | Carl Roth, Graz, Austria | Cat#HN08 |
| HEPES | Carl Roth, Graz, Austria | Cat#9105 |
| D(+)-Glucose Monohydrate | Carl Roth, Graz, Austria | Cat#6780 |
| Oligomycin-A | Tocris, Bristol, UK or Sigma Aldrich, Vienna, Austria | Cat#4110 or Cat#75351 |
| D-Mannitol | Sigma Aldrich, Vienna, Austria | Cat#M4125 |
| Gibco™ MEM Vitamin solution (100x) | Thermo Fisher Scientific, Vienna, Austria | Cat#11120052 |
| Gibco™ MEM Amino Acid solution (50x) | Thermo Fisher Scientific, Vienna, Austria | Cat#11130051 |
| Penicillin-Streptomycin (10,000U/ml) | Thermo Fisher Scientific, Vienna, Austria | Cat#15140122 |
| Amphotericin B | Thermo Fisher Scientific, Vienna, Austria | Cat#15290018 |
| TransFast™ Transfection Reagent | Promega, Walldorf, Germany | Cat#E2431 |
| PolyJet™ In Vitro DNA Transfection Reagent | SignaGen® Laboratories, Rockville, MD, USA | Cat#SL100688 |
| Human: HeLa S3 | ATCC, Guernsey, UK | N/A |
| Human: HEK293a | ATCC, Guernsey, UK | N/A |
| Rat: INS-1 (832/13) | C.B. Newgard, Duke University School of Medicine, USA | N/A |
| pcDNA3.1 mtAT1.03 | H. Imamura; | N/A |
| Visiview v4.2.0.1 | N/A | |
| GraphPad Prism v5.01 | N/A | |
| Microsoft Excel 2013 | N/A | |
| Fiji/ImageJ | ||
| Incubator HeraCell | Heraeus Holding GmbH, Hanau, Germany | N/A |
| Sterile Workbench HeraSafe | Heraeus Holding GmbH, Hanau, Germany | N/A |
| 30mm Coverslip Glasses | Paul Marienfeld GmbH & Co. KG, Lauda-Königshofen, Germany | Cat#0111700 |
| 6-well Plates | Greiner Bio-One International GmbH, Kremsmünster, Austria | Cat#657160 |
| Perfusion System | NGFI Next Generation Fluorescence Imaging GmbH, Graz, Austria | N/A |
| Perfusion Chamber PC30 | NGFI Next Generation Fluorescence Imaging GmbH, Graz, Austria | N/A |
| Chemistry diaphragm pump ME 1c (vacuum pump) | Vacuubrand, Wertheim, Germany | N/A |
| Fluorescence microscopy setup | see Equipment | N/A |